China NMPA Drug Inspection - Guizhou Anshun Xixiu Pharmaceutical Co., Ltd. - Cold and flu granules
China NMPA drug inspection for Guizhou Anshun Xixiu Pharmaceutical Co., Ltd. published July 12, 2018. Drug: Cold and flu granules. The Sichuan Provincial Food and Drug Administration issued a comprehensive drug quality announcement (Fifth Issue, 2018)
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Guizhou Anshun Xixiu Pharmaceutical Co., Ltd. published July 12, 2018. Drug: Cold and flu granules. The Sichuan Provincial Food and Drug Administration issued a comprehensive drug quality announcement (Fifth Issue, 2018)
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox